Health Care

The company that runs New York Sports Club and Lucille Roberts gyms filed for bankruptcy protection on Monday, as business and memberships decline at gyms in parts of the nation still grapple with the novel coronavirus pandemic.

Gilead Sciences Inc will acquire biopharmaceutical company Immunomedics Inc for $21 billion in a deal that would further expand Gilead's portfolio of cancer treatments, the companies said on Sunday in a statement.

While Bourla acknowledged the possibility Pfizer's vaccine candidate could fail, he argued that he doesn't believe any potential financial hit will "break the company" despite investing at least $1.5 billion in the effort.

Pfizer and BioNTech reiterated that results from their vaccine candidate's late-stage trial could be available as early as October.

Dr. Anthony Fauci told actress Jennifer Garner that he believes Americans can return to theaters again once a coronavirus vaccine has existed "for almost a year."

The U.S. added 47,643 new coronavirus cases Friday, the largest daily increase in a week, according to data compiled by Johns Hopkins University.

Authorities have been on high alert to avoid fresh outbreaks, and provinces including British Columbia have imposed new curbs to tackle the spread of the virus.

Oxford University says trials of a coronavirus vaccine that it is developing with pharmaceutical company AstraZeneca will resume, days after being paused due to a reported side-effect in a patient in the U.K.

Many health-care companies and hospital industry groups are fighting a Trump administration policy tying extra federal coronavirus reimbursements to test results proving that patients are positive for Covid-19.

The International Air Transport Association is warning governments across the globe that the air cargo industry may potentially face severe capacity constraints that could hinder the timely distribution of a COVID-19 vaccine. 

Ex-Theranos CEO Elizabeth Holmes may claim mental illness as her defense.

AstraZeneca should still know before the end of the year whether its experimental vaccine protects people against COVID-19, the drugmaker’s chief executive Pascal Soriot said on Thursday, as long as it can resume trials soon.

AstraZeneca pausing the trial of the coronavirus vaccine is an indication that the process is “safe,” White House adviser Dr. Scott Atlas told FOX Business’ “Mornings with Maria” on Wednesday.

AstraZeneca shares have plunged more than 7% in after-hours trading following news that the company's Phase 3 trial for its COVID-19 vaccine has been put on hold due to safety concerns.

The company will effectively join other third-party manufacturers helping Inovio scale up production of its experimental vaccine, INO-4800. 

Sanitizers should be primarily alcohol based with few other additives, health officials say.

According to El-Erian, lawmakers on Capitol Hill should be focusing on a four-prong strategy to help stimulate the economy.

Major COVID-19 vaccine developers are to release a joint statement this week vowing to prioritize safety before speed by waiting to seek emergency government approval for the vaccine until human trials show "substantial evidence of safety and efficacy," according to a report.

Serbia and Pakistan are among the new countries agreeing to Phase 3 trials, as the two companies seek more data overseas amid dwindling new cases in China.